Torrent Pharmaceuticals is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals in a Rs. 25,689 Crore deal, aiming to enhance its market presence and operational synergy in the pharmaceutical industry.

Information on the Target

JB Chemicals and Pharmaceuticals Limited is a rapidly expanding Indian pharmaceutical company renowned for its leadership in hypertension and chronic therapies. The company boasts six brands that rank among the top 300 in the Indian Pharmaceutical Market (IPM) and stands out as a leading Contract Development and Manufacturing Organization (CDMO) specializing in medicated lozenges. JB Pharmaceuticals operates with a robust international presence across more than 40 countries, including significant markets such as Russia, South Africa, and the USA, underpinned by eight manufacturing facilities that are globally certified.

Industry Overview in India

The Indian pharmaceutical industry is one of the largest in the world, characterized by rapid growth propelled by increasing healthcare expenditure, an expanding population, and rising chronic disease prevalence. The sector is renowned for its diverse product offerings, including generic medicines, over-the-counter drugs, and complex therapies, which provide comprehensive solutions for a wide range of health issues.

India's strategic focus on research and development has rooted its position in the global market, where a significant portion of its output is directed towards export. Furthermore